For decades, stimulant medications such as Adderall and Ritalin have been the backbone of clinical treatment for attention deficit hyperactivity disorder (ADHD) worldwide, a condition that affects millions of children and adults. In Malaysia, the primary medications approved and used to treat ADHD are methylphenidate (a stimulant) and atomoxetine (a non-stimulant). 

These drugs are among the most commonly prescribed psychiatric medicines in childhood. They have long been understood to work by strengthening the brain’s attention-control systems, allowing individuals with ADHD to focus, regulate behaviour, and manage impulsivity more effectively.

New research now challenges that long-held belief.

A large neuroimaging study led by scientists at a leading medical school in the United States suggests that stimulant medications may not directly improve attention in the way doctors have been taught for years.

Instead, the drugs appear to exert their strongest effects on brain networks linked to reward, alertness, and wakefulness. The resulting boost in attention may be an indirect consequence rather than the primary action.

The findings are already prompting renewed discussion among clinicians, educators, and families. They raise fresh questions about how ADHD medications actually work, why they are effective for many children, and what their long-term impact on brain development might be.

ADHD is one of the most common neurodevelopmental disorders of childhood. It is estimated to affect more than seven million children in the United States alone, with symptoms often persisting into adulthood. In Malaysia, the reported prevalence of ADHD is often cited around 3.9%, but experts believe the actual rate is significantly higher due to underdiagnosis, with estimates ranging from 1.6% to 4.6% in some sources and even higher for children (around 5.29%)

Inattention, impulsivity, and hyperactivity can disrupt learning, social development, and emotional wellbeing. Around 3.5 million American children aged three to 17 currently take medication to manage the condition, according to study.

Stimulants remain the first-line treatment in many countries. They are known to improve classroom behaviour, test performance, and task completion. Yet the precise brain mechanisms behind these improvements have remained partly theoretical.

The new study, published in a peer-reviewed journal Cell, used brain imaging data from nearly 6,000 children aged eight to 11. The data were drawn from the Adolescent Brain Cognitive Development Study, the largest long-term investigation of child brain development and health ever conducted in the United States.

Researchers compared brain scans from children who were taking stimulant medication with those who were not, focusing on how different brain regions communicated with each other.

The results were striking.

Rather than enhancing communication in brain areas traditionally associated with attention control, stimulant medications altered activity in networks involved in motivation, reward processing, and arousal. Children taking the drugs showed brain patterns consistent with higher alertness and increased engagement. Tasks appeared more interesting or rewarding, even if the child would normally struggle to sustain interest.

In practical terms, this means that improved attention may arise because children feel more awake and more motivated, not because their core capacity for attention has been directly strengthened.

The researchers also observed that the brain activity patterns associated with stimulant use closely resembled those seen after a good night’s sleep. In some cases, the medications seemed to counteract the effects of sleep deprivation. This finding is particularly notable given growing evidence linking ADHD symptoms with poor or disrupted sleep.

To test whether these effects were specific to children with ADHD, scientists also examined a small group of healthy adults who did not have the condition. When given stimulant medication, these adults showed similar changes in brain activity. This suggests that the drugs act on fundamental brain systems related to wakefulness and reward, regardless of whether ADHD is present.

The study also confirmed what many parents and teachers already observe. Children taking stimulant medication tended to perform better academically and scored higher on cognitive tests. However, the researchers emphasised that the pathway to these improvements may differ from previous assumptions.

Experts involved in the study noted that this new perspective could help explain a long-standing puzzle in ADHD treatment. Stimulants, despite their name, often calm hyperactive children rather than making them more restless. By increasing alertness and making tasks more rewarding, the brain may no longer seek constant stimulation through movement or impulsive behaviour.

While the findings offer valuable insight, they also raise concerns.

One key issue is sleep. Previous research has shown that sleep disturbances are extremely common in children and adolescents with ADHD. Some studies estimate that up to three-quarters experience chronic sleep problems, including difficulty falling asleep, frequent night awakenings, or insufficient sleep duration.

If stimulant medications mimic the brain effects of good sleep, they may mask underlying sleep deficits rather than address them. A child who is chronically sleep-deprived may appear more focused during the day while on medication, even though the root problem remains untreated.

Researchers warn that this could have long-term consequences. Sleep plays a crucial role in brain development, emotional regulation, and physical health. Covering up sleep deprivation with medication may delay diagnosis of sleep disorders such as insomnia, circadian rhythm disruption, or sleep apnoea.

There is also uncertainty about the long-term effects of altering reward and wakefulness systems in the developing brain. Some scientists speculate that stimulants may have a beneficial corrective effect, possibly by improving cellular maintenance processes in the brain. Others caution that prolonged use could interfere with natural sleep-wake regulation or emotional processing.

At present, the evidence does not support abrupt changes to prescribing practices. Stimulant medications have a strong track record of improving daily functioning and quality of life for many individuals with ADHD. The new findings do not suggest that the drugs are ineffective. Rather, they indicate that their benefits may arise through different biological pathways than previously assumed.

For clinicians, the study highlights the importance of looking beyond daytime behaviour alone. ADHD may need to be viewed as a round-the-clock condition, with sleep, routine, and environmental factors playing a central role. Comprehensive care may require closer monitoring of sleep patterns alongside medication use.

For families, the research underscores the value of good sleep hygiene. Consistent bedtimes, reduced screen exposure at night, and age-appropriate sleep duration remain essential, even when medication appears to be working well. Medication should not be seen as a substitute for sleep.

The study’s authors stress that further research is needed. Long-term studies will be crucial to determine how stimulant-induced changes in brain activity evolve over time. Scientists also hope to explore whether different medications produce similar effects, and whether non-stimulant treatments influence attention through alternative pathways.

There is also growing interest in personalised treatment approaches. If ADHD symptoms are partly driven by sleep disruption in some children, targeted sleep interventions could reduce the need for higher medication doses. Behavioural therapies, lifestyle adjustments, and school-based support may become even more important components of care.

The findings arrive at a time of broader debate about the rising use of psychiatric medication in children. While prescriptions have helped countless families manage challenging symptoms, there is increasing demand for a deeper understanding of how these drugs interact with developing brains.

The study does not overturn decades of clinical practice, but it does invite a shift in perspective. Attention may improve not because the brain’s focus switch is directly turned up, but because the child feels more awake, more engaged, and more motivated to participate.

That distinction matters. It opens the door to new research, more nuanced treatment strategies, and a more holistic view of ADHD as a condition shaped by brain biology, sleep, environment, and daily experience.

As scientists continue to unravel the complex mechanisms behind ADHD and its treatments, one message is clear. Effective care requires more than managing symptoms in the classroom. It requires understanding the child’s brain across the full 24-hour day, including the hours spent asleep.